POAS
Phaos Technology Holdings (Caym
There isn't enough reported data to score POAS yet.
POAS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
POAS's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
POAS PE Valuation
POAS has no meaningful PE right now: it lost money over the past year.
POAS Forward outlook
There aren't enough analyst estimates for POAS to show an outlook.
POAS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$5.73 | -$3.39 |
POAS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $102.9K | -21% |
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -4707% | N/A |
| Q2 2025 | -3148% | N/A |
POAS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$8.5M | -$5.5M |
POAS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -51% | -870K shares |
POAS Net Leverage
POAS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
POAS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 21.1 | Neutral |
POAS's weekly RSI is 36 (neutral) and its Stochastic is 21 (neutral).
POAS PE vs Healthcare Sector
POAS has no meaningful PE right now: it lost money over the past year.
POAS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.03 | 48% above |
| 20 week MA | $2.59 | 16% above |
| 50 week MA | $21.3 | 86% below |
POAS has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 86% below its 50-week average.
POAS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $60.2 | $57.0 | -5.2% |
| 2026 YTD | $57.0 | $3.01 | -95% |
POAS has finished every year since 2025 lower, and it's down 95% so far in 2026.